Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro Ruchika Sharma30 Dec 2025 6:08 PM ISTGlobal drugmakers Novo Nordisk and Eli Lilly have kicked off a price battle in China’s obesity treatment market, cutting prices of their blockbuster...
Cipla Gets CDSCO Panel Nod to Begin Phase III Study of Semaglutide Injection Susmita Roy30 Dec 2025 2:27 PM ISTNew Delhi: Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
Semaglutide Reduces Hospital Admissions of Obese Patients Beyond Cardiovascular Benefits: JAMA Medha Baranwal26 Dec 2025 11:30 AM ISTAustralia: In a prespecified exploratory analysis of the SELECT randomized clinical trial, participants were found to have a high baseline burden of...
Novo Nordisk seeks USFDA approval for once weekly CagriSema for weight management Ruchika Sharma21 Dec 2025 2:30 PM ISTPlainsboro: Novo Nordisk has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...
Semaglutide Significantly Improves Glycemia and Weight in Schizophrenia: JAMA Dr Riya Dave19 Dec 2025 8:45 PM ISTAccording to a new study published in JAMA Psychiatry, adjunctive semaglutide was shown to significantly improve glycemic control and weight outcomes...
GLP-1 Drugs Linked to Lower Cataract and Dry AMD Risk: Study Dr Riya Dave15 Dec 2025 9:00 PM ISTRecent studies show that GLP-1 receptor agonists are associated with a significantly reduced risk of age-related cataracts and a lower risk of...
Tirzepatide Shows Lower Mortality and Better Cardiorenal Outcomes than Semaglutide in Coronary Artery Disease and Obesity: AHJ Study, December 2025 Dr. Bhumika Maikhuri15 Dec 2025 11:15 AM ISTIn patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced cardiovascular and renal...
Novo Nordisk Gets CDSCO Panel Nod to Update Wegovy Label With New Safety, Pharmacodynamics Data Susmita Roy14 Dec 2025 12:43 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo...
Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac Susmita Roy10 Dec 2025 5:37 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) recorded a steady rise in November 2025, growing 9.06% month-on-month (MoM) in value, even as unit...
Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
